[go: up one dir, main page]

DE602004019818D1 - Pharmazeutische zusammensetzungen mit platin-komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen - Google Patents

Pharmazeutische zusammensetzungen mit platin-komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen

Info

Publication number
DE602004019818D1
DE602004019818D1 DE602004019818T DE602004019818T DE602004019818D1 DE 602004019818 D1 DE602004019818 D1 DE 602004019818D1 DE 602004019818 T DE602004019818 T DE 602004019818T DE 602004019818 T DE602004019818 T DE 602004019818T DE 602004019818 D1 DE602004019818 D1 DE 602004019818D1
Authority
DE
Germany
Prior art keywords
xanothes
pharmaceutical compositions
platinum complexes
therapeutic applications
complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004019818T
Other languages
English (en)
Inventor
Eberhard Amtmann
Wolfgang Friebolin
Gerhard Schilling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Universitaet Heidelberg
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Universitaet Heidelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ, Universitaet Heidelberg filed Critical Deutsches Krebsforschungszentrum DKFZ
Publication of DE602004019818D1 publication Critical patent/DE602004019818D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602004019818T 2003-12-10 2004-12-10 Pharmazeutische zusammensetzungen mit platin-komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen Expired - Fee Related DE602004019818D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03028298A EP1541142A1 (de) 2003-12-10 2003-12-10 Pharmazeutische Zubereitungen enthaltend einen Platin Komplex mit einem zweiwertigen Xanthat und die therapeutische Verwendung der Zubereitungen
PCT/EP2004/014110 WO2005058307A1 (en) 2003-12-10 2004-12-10 Pharmaceutical compositions containing platinum complexes with secondary xanthates and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
DE602004019818D1 true DE602004019818D1 (de) 2009-04-16

Family

ID=34486158

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004019818T Expired - Fee Related DE602004019818D1 (de) 2003-12-10 2004-12-10 Pharmazeutische zusammensetzungen mit platin-komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen

Country Status (9)

Country Link
US (1) US20070248570A1 (de)
EP (2) EP1541142A1 (de)
AT (1) ATE424196T1 (de)
CA (1) CA2550280A1 (de)
DE (1) DE602004019818D1 (de)
DK (1) DK1708693T3 (de)
ES (1) ES2323589T3 (de)
PT (1) PT1708693E (de)
WO (1) WO2005058307A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8846712B2 (en) 2011-09-12 2014-09-30 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (de) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamidderivate als kinaseinhibitoren
EP2847191B1 (de) 2012-05-09 2016-06-15 Sanofi Substituierte 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridin-derivate als kinaseinhibitoren
WO2023093837A1 (zh) * 2021-11-26 2023-06-01 湖南湘源美东医药科技有限公司 含有铂类药物或者铂类药物共晶的药物组合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000010543A2 (de) * 1998-08-25 2000-03-02 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Arzneimittel enthaltend platinkomplexverbindungen sowie deren verwendung

Also Published As

Publication number Publication date
DK1708693T3 (da) 2009-06-29
EP1541142A1 (de) 2005-06-15
ATE424196T1 (de) 2009-03-15
US20070248570A1 (en) 2007-10-25
WO2005058307A1 (en) 2005-06-30
CA2550280A1 (en) 2005-06-30
ES2323589T3 (es) 2009-07-21
PT1708693E (pt) 2009-06-02
EP1708693B1 (de) 2009-03-04
EP1708693A1 (de) 2006-10-11

Similar Documents

Publication Publication Date Title
CY1118480T1 (el) Παραγωγα toy uk-2a
DE602004008105D1 (de) 42-o-alkoxyalkylrapamycinderivate und diese enthaltende zusammensetzungen
BRPI0410503B8 (pt) composição tópica e uso da composição
DE602004026113D1 (de) Glp-1-verbindungen
AR027355A1 (es) Acidos tiazolidincarboxilicos
CY2013004I2 (el) Προϊοντα συζευξης auristatin και χρηση αυτων για θεραπεια καρκινου, αυτοανοσης ασθενειας ή μολυσματωδους ασθενειας
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
SE0301700D0 (sv) Novel compounds
DE60143857D1 (de) Zusammensetzung bestehend aus phy906 und chemotherapeutika
CY1110405T1 (el) Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
BRPI0411743A (pt) método e composições para tratar doenças relacionadas a amilóides
ATE243692T1 (de) Arylaminderivate und ihre verwendung als antitelomerasemittel
ATE508114T1 (de) Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
ATE236147T1 (de) Derivate von flavonen, xanthonen und kumarinen
BRPI0407234A (pt) Heterociclos substituìdos
ATE231872T1 (de) Thiazolopyrimidinderivate
ATE401875T1 (de) Pharmazeutische feste dispersionen von modafinil- verbindungen
ATE319718T1 (de) Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
SE0301650D0 (sv) Novel compounds
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
ATE368649T1 (de) Cyanoguanidin prodrugs
DE602004019818D1 (de) Pharmazeutische zusammensetzungen mit platin-komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee